Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma
NCT01588704
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
Neoadjuvant Bevacizumab
Sponsor
Si-Yu Wang